Sagent Pharmaceuticals Inc (SGNT) financial statements (2022 and earlier)

Company profile

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700
SCHAUMBURG, IL 60195
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments49,02274,106156,14264,292
Cash and cash equivalents28,96255,63342,33227,687
Short-term investments20,06018,473113,81036,605
Receivables54,10344,93626,67733,049
Inventory, net of allowances, customer advances and progress billings76,45361,78146,48147,106
Inventory76,45361,78146,48147,106
Disposal group, including discontinued operation4,626   
Prepaid expense and other current assets2,821
Other undisclosed current assets7,38817,6956,491 
Total current assets:191,592198,518235,791147,268
Noncurrent Assets
Property, plant and equipment19,76171,15357,684780
Long-term investments and receivables7,1084,5392,06319,622
Long-term investments7,1084,5392,06319,622
Intangible assets, net (including goodwill)78,35093,73014,3644,277
Goodwill25,18428,1556,038 
Intangible assets, net (excluding goodwill)53,16665,5758,3264,277
Deferred costs  28284
Other noncurrent assets2,113375306
Prepaid expense and other noncurrent assets368
Other undisclosed noncurrent assets50,80813,173(28)(284)
Total noncurrent assets:158,140182,97074,41725,047
TOTAL ASSETS:349,732381,488310,208172,315
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities59,40962,42544,97930,393
Accounts payable43,70332,71024,93721,813
Accrued liabilities15,70619,34613,0047,369
Employee-related liabilities 9,3296,1431,211
Taxes payable 1,040895 
Debt 50810,333 
Due to related parties13,7548,0793,1297,026
Disposal group, including discontinued operation2,910   
Other undisclosed current liabilities7,58214,5395,0833,035
Total current liabilities:83,65585,55163,52440,454
Noncurrent Liabilities
Long-term debt and lease obligation1,6231,94510,333 
Long-term debt, excluding current maturities1,6231,94510,333 
Liabilities, other than long-term debt13,36118,2402,33512
Deferred tax liabilities, net12,02115,70666
Other liabilities1,3402,5342,3296
Other undisclosed noncurrent liabilities  (2,010)(6)
Total noncurrent liabilities:14,98420,18510,6586
Total liabilities:98,639105,73674,18240,460
Stockholders' equity
Stockholders' equity attributable to parent251,093275,752236,026131,855
Common stock328320318281
Additional paid in capital367,235352,982349,278272,725
Accumulated other comprehensive income (loss)(17,482)(3,374)4872,500
Accumulated deficit(98,988)(74,176)(114,057)(143,651)
Total stockholders' equity:251,093275,752236,026131,855
TOTAL LIABILITIES AND EQUITY:349,732381,488310,208172,315

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
318,296288,983244,750183,615
Cost of revenue
(Cost of Goods and Services Sold)
(230,557)(202,821)(167,228)(152,508)
Gross profit:87,73986,16277,52231,107
Operating expenses(84,655)(67,118)(54,078)(46,600)
Other undisclosed operating income (loss)(47,605) 7,936 
Operating income (loss):(44,521)19,04431,380(15,493)
Nonoperating income (expense)(2,790)(678)5,000243
Investment income, nonoperating 375 243
Gain on contract termination  5,000 
Foreign currency transaction gain, before tax2,8381,075  
Interest and debt expense(770)(2,188)(930)(1,567)
Income (loss) from continuing operations before equity method investments, income taxes:(48,081)16,17835,450(16,817)
Income from equity method investments 3,9872,3951,337
Other undisclosed loss from continuing operations before income taxes (3,987)(7,356)(1,337)
Income (loss) from continuing operations before income taxes:(48,081)16,17830,489(16,817)
Income tax expense (benefit)26,19923,703(895) 
Net income (loss) available to common stockholders, diluted:(21,882)39,88129,594(16,817)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(21,882)39,88129,594(16,817)
Other comprehensive loss(14,108)(3,861)(2,013) 
Comprehensive income (loss):(35,990)36,02027,581(16,817)
Other undisclosed comprehensive income, net of tax, attributable to parent   338
Comprehensive income (loss), net of tax, attributable to parent:(35,990)36,02027,581(16,479)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: